secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2025-04-10T23:59:59+00:00
Accession:  0001558370-25-004651
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NextCure updates corporate presentation on LNCB74 trial; no specific data disclosed
--------------------------------------------------------------------------------

- Updated presentation for LNCB74, a clinical-stage candidate, furnished on April 10, 2025.
- Company engaging with investment community referencing updated materials.
- No new clinical data, enrollment figures, or milestones provided in the filing or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025004651/0001558370-25-004651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025004651/nxtc-20250410x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-004651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer